This is a link post for the Biosecurity Fundamentals Curriculum
Core:
Centre for Long Term Resilience Future Proof report
◦ “Biosecurity” Pages 16-22 (20 mins)
Preventing Global Catastrophic Biological Risks
◦ Executive summary (5-8) and Recommendations (19-22) (20 mins)
◦ OR Jaime Yassif's EAG talk on the same report (as well as a recap on NTI’s work to reduce GCBRs) (30 mins)
Optional:
General resources
◦ An FLI podcast on the history of biotech governance
◦ An analysis of how security-motivated policy can conflict with other public health interests
◦ The careers and policies that can prevent global catastrophic biological risks, according to world-leading health security expert Dr Inglesby, April 18 2018.
◦ WHO report: Emerging technologies and dual-use concerns: a horizon scan for global public health
Regulating new technologies
◦ Regulation of Synthetic Biology: Developments Under the Convention on Biological Diversity and Its Protocols, Felicity Keiper and Ana Atanassova, Frontiers in Bioengineering and Biotechnology, April 2020.
◦ Synthetic Genomics: Options for Governance (Executive summary probably sufficient.)
◦ DNA Synthesis and Biosecurity: Lessons Learned and Options for the Future (‘Story so far’ on US governance and sequence screening. Concisely summarized here).
◦ A paper summarising the regulation of synthetic biology from a biosafety and biosecurity perspective
COVID-19 Response
◦ COVID-19, SARS-CoV-2, and Export Controls, Piers Millett and Paul Rutten, Health Security, August 2020
◦ Risk Communication Strategies for the Very Worst of Cases, Monica Schoch-Spana et al., Johns Hopkins Center for Health Security, March 2019.
◦ Our World in Data Exemplars in Global Health
▪ Vietnam
▪ Germany
▪ South Korea
◦ Institute for Progress on Emergency Use Authorization
Table-top exercises (descriptions from Tessa)
◦ Event 201, October 18, 2019. (Explored incentives for producing vaccine stockpiles, economic effects of trade and travel restrictions, potential ramifications of a pandemic for the global financial system, and mis- and dis-information. Participants included representatives from UPS, Johnson & Johnson, Gates Foundation, NBCUniversal, and others.)
◦ Clade X, May 15, 2018. (Explored decisions available to US national security personnel in the event of an emerging engineered pandemic. Participants included a former senator, the president of AAAS, a former CDC director, and others.)
◦ Navigating the Storm: Report and Recommendations from the Atlantic Storm Exercise (TTX of deliberate international smallpox attack)
US-specific biosecurity policies
◦ Health Security Memos to the New Administration and Congress (CHS led recommendations to US Gov in 2017. Mostly ‘bottom line’ recommendations.)
◦ Federal Funding for Health Security in FY2018 (US government)
▪ Public Health Preparedness Funding: Key Programs and Trends From 2001 to 2017
◦ President’s Council of Scientific Advisors Biodefense Report
▪ Focus on PCAST’s Recommendations (pages 14-16), but skim the rest of the document to provide context (30 mins)
